MM_Hub: CONGRESS|#EHA2021|Francesca Gay, University of Torino highlighted the need for comprehensive baseline evaluation of prognostic factors. Approved therapies with suboptimal efficacy are available but there is a need for a new approach. MRD driven therapies are needed #mmsm #myeloma

by | Jun 14, 2021 | Twitter | 0 comments

CONGRESS|#EHA2021|Francesca Gay, University of Torino highlighted the need for comprehensive baseline evaluation of prognostic factors. Approved therapies with suboptimal efficacy are available but there is a need for a new approach. MRD driven therapies are needed #mmsm #myeloma pic.twitter.com/LK3h7x29du

— Multiple Myeloma Hub (@MM_Hub) June 14, 2021

Submit a Comment